Scholarlink

<p>Transglutaminase 2 (TG2) is a multifunctional enzyme widely implicated in neuroinflammation and extracellular matrix (ECM) remodeling after central nervous system (CNS) injury and diseases. In spinal cord injury (SCI), TG2 contributes significantly to pathology through ECM remodeling and glial scar formation. Here, we explored the intracellular roles of TG2 following severe spinal cord compression injury, utilizing TG2 knockout (KO) mice and pharmacological inhibition via cystamine. Genetic deletion or inhibition of TG2 significantly improved locomotor function and promoted enhanced preservation of white and gray matter post-injury. Mechanistically, TG2 KO reduced fibronectin deposition, chondroitin sulfate proteoglycan accumulation, and reactive gliosis. Importantly, imaging mass cytometry revealed that TG2 deletion attenuated cellular stress responses, including reductions in ER stress markers (GRP78), oxidative stress mediators (pNrf2), mitochondrial dysfunction indicators (BNIP3 and cytochrome c), and increased neuronal expression of survival-associated (pREL-NFκB). These results highlight a novel intracellular function for TG2 in exacerbating neurodegeneration through modulation of cellular stress pathways, offering promising therapeutic implications for SCI recovery.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Removal or inhibition of transglutaminase 2 decreases cellular stress, supporting tissue preservation, and recovery after SCI

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月23日

查看全文
  • Mousumi Ghosh,
  • Omar Elwardany,
  • Xiaoqi Pan,
  • Shannon Jacqueline Saigh,
  • Damien D. Pearse

摘要

Transglutaminase 2 (TG2) is a multifunctional enzyme widely implicated in neuroinflammation and extracellular matrix (ECM) remodeling after central nervous system (CNS) injury and diseases. In spinal cord injury (SCI), TG2 contributes significantly to pathology through ECM remodeling and glial scar formation. Here, we explored the intracellular roles of TG2 following severe spinal cord compression injury, utilizing TG2 knockout (KO) mice and pharmacological inhibition via cystamine. Genetic deletion or inhibition of TG2 significantly improved locomotor function and promoted enhanced preservation of white and gray matter post-injury. Mechanistically, TG2 KO reduced fibronectin deposition, chondroitin sulfate proteoglycan accumulation, and reactive gliosis. Importantly, imaging mass cytometry revealed that TG2 deletion attenuated cellular stress responses, including reductions in ER stress markers (GRP78), oxidative stress mediators (pNrf2), mitochondrial dysfunction indicators (BNIP3 and cytochrome c), and increased neuronal expression of survival-associated (pREL-NFκB). These results highlight a novel intracellular function for TG2 in exacerbating neurodegeneration through modulation of cellular stress pathways, offering promising therapeutic implications for SCI recovery.